Biological Therapy (Also Called Immunotherapy Or Brm, Biological Response Modifier Therapy)

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Local students are honored by colleges, universities

Published July 6, 2009, 12:39 am, Observer-Tribune

Area students have been honored by their colleges and universities.

Discover News | Full Story


Researchers find new technique to monitor protein changes in mouse

Published July 5, 2009, 10:48 pm, PharmaBiz

A new imaging technique can monitor, in living mice, the HER2 protein found in above-normal amounts in many cases of breast cancer as well as some ovarian, prostate and lung cancers.

Discover News | Full Story


Lifeblood veteran forms Key Biologics

Published July 5, 2009, 9:12 pm, BizJournals

Former Lifeblood CEO Edward Scott has purchased the nonprofit’s biological services division, now called Key Biologics LLC, at a time when the cellular therapy market is on the cusp of a possible commercial breakthrough.

Discover News | Full Story


Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

Published July 5, 2009, 8:14 pm, redOrbit

EMERYVILLE, Calif. and HUENENBERG, Switzerland, July 5 /PRNewswire-FirstCall/ -- Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc.

Discover News | Full Story


Alcon Commences Phase 2 Clinical Trial of NovaBays NVC-422 for Viral Conjunctivitis

Published July 5, 2009, 3:14 pm, Finanzen.net

Alcon, Inc. (NYSE: ACL ) ...

Discover News | Full Story


Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

Published July 5, 2009, 3:00 pm, PR Newswire via Yahoo! Finance

Alcon, Inc. and its partner, NovaBay Pharmaceuticals, Inc. , announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay's patented lead Aganocide® compound, NVC-422, for viral conjunctivitis, a type of "pink eye".

Discover News | Full Story


Targeting cancer cells

Published July 5, 2009, 11:37 am, Minneapolis-St. Paul Star Tribune

A small Washington County company is working toward what could be a breakthrough: a drug that kills only cancer cells.

Discover News | Full Story


Ailing pets propel profusion of care

Published July 5, 2009, 7:20 am, The Buffalo News

The patient was lying on his side, asleep under anesthesia, as a machine measuring his breathing beeped soothingly.

Discover News | Full Story


The diversity challenge

Published July 5, 2009, 4:11 am, Columbia Daily Tribune

The University of Missouri has a number of programs to recruit minorities to the Columbia campus and retain them once they get there.

Discover News | Full Story


Cambridge eyes biolab rules

Published July 4, 2009, 9:16 pm, Boston Herald

Cambridge officials are taking steps to prohibit the most dangerous biolabs from setting up shop in the city, hoping to avoid the kinds of protests that have rocked Boston...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a